[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100645143":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":29,"locations":35,"responsibleParty":54,"collaborators":24,"id":57,"slug":24,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":24,"eligibilityCriteria":62,"healthyVolunteers":58,"sex":63,"minAge":64,"maxAge":65,"enrollmentInfo":66,"targetDuration":24,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":24,"overallStatus":37,"whyStopped":24,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"Ain Shams University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Group A (Nd:YAG Group):","EXPERIMENTAL","Patients will receive Nd:YAG laser (1064 nm) + injection sclerotherapy (CLaCS).",[13],"Device: Nd:YAG laser",{"label":15,"type":10,"description":16,"interventionNames":17},"Group B (Diode Group)","Patients will receive Diode laser (980 nm) + injection sclerotherapy (CLaCS).",[18],"Drug: Diode laser",[20,25],{"type":21,"name":22,"description":11,"armGroupLabels":23,"otherNames":24},"DEVICE","Nd:YAG laser",[9],null,{"type":26,"name":27,"description":16,"armGroupLabels":28,"otherNames":24},"DRUG","Diode laser",[15],[30],{"name":31,"role":32,"phone":33,"phoneExt":24,"email":34},"Mohamed A Hagag, MD","CONTACT","00201126560324","hagagmohamed@med.asu.edu.eg",[36],{"facility":5,"status":37,"city":38,"state":24,"zip":39,"country":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"RECRUITING","Cairo","11591","Egypt",{"type":42,"coordinates":43},"Point",[44,45],31.24967,30.06263,{"lat":45,"lon":44},[48,49,52],{"name":31,"role":32,"phone":33,"phoneExt":24,"email":34},{"name":50,"role":51,"phone":24,"phoneExt":24,"email":24},"Ahmed G Abdellattif, MD","PRINCIPAL_INVESTIGATOR",{"name":53,"role":51,"phone":24,"phoneExt":24,"email":24},"Mina G Basta, MD",{"type":51,"investigatorFullName":55,"investigatorTitle":56,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"MohamedAhmed","Lecturer of Vascular Surgery, Faculty of Medicine, Ain Shams University, Cairo, Egypt.","100645143",false,"NCT07678697","Nd:YAG Laser Combined With Injection Sclerotherapy Versus Diode Laser in the Treatment of Reticular Veins and Telangiectasias Using CLaCS Technique","Comparative Study Between Nd:YAG Laser Combined With Injection Sclerotherapy Versus Diode Laser in the Treatment of Reticular Veins and Telangiectasias Using CLaCS Technique","Inclusion Criteria:\n\n* Patients aged 18-60 years.\n* Both sexes.\n* Presence of reticular veins and\u002For telangiectasias (CEAP classification C1).\n* Fitzpatrick skin types II-V.\n* Patients seeking cosmetic treatment.\n\nExclusion Criteria:\n\n* Pregnancy or lactation.\n* History of deep vein thrombosis.\n* Coagulation disorders.\n* Allergy to sclerosant agents.\n* Active skin infection at treatment site.\n* Previous treatment of target veins within 6 months.\n* Great saphenous vein or short saphenous vein incompetence.\n* Deep venous insufficiency or thrombosis.\n* Abnormal venous duplex findings.","ALL","18 Years","60 Years",{"count":67,"type":68},80,"ESTIMATED","INTERVENTIONAL",[71],"NA","This study aims to compare the efficacy (in terms of vein clearance) and safety of Nd:YAG laser combined with injection sclerotherapy versus diode laser combined with injection sclerotherapy in the treatment of reticular veins and telangiectasias using the Cryo-Laser and Cryo-Sclerotherapy (CLaCS) technique.",[74,75,76,77,78,79],"Nd:YAG Laser","Sclerotherapy","Diode Laser","Reticular Veins","Telangiectasias","CLaCS Technique","2026-06-25",{"date":82,"type":83},"2026-07-01","ACTUAL",{"date":85,"type":83},"2026-06-01",{"date":87,"type":68},"2026-12-01",{"name":5,"class":6},1]